Organogenesis Holdings Inc.
ORGO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 11.3% | -3.9% | -3.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 76% | 75.4% | 76.7% | 75.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 3.3% | 8.3% | 8.9% | 18.6% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 0.2% | 1.1% | 3.4% | 20.2% |
| EPS Diluted | 0.007 | 0.037 | 0.12 | 0.7 |
| % Growth | -82.6% | -68.9% | -82.9% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |